A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.
Oncolytic adenoviruses, such as ONYX-015, have been tested in clinical trials for currently untreatable tumors, but have yet to demonstrate adequate therapeutic efficacy. The extent to which viruses infect targeted cells determines the efficacy of this approach but many tumors down-regulate the Coxs...
Guardado en:
Autores principales: | Neda Bagheri, Marisa Shiina, Douglas A Lauffenburger, W Michael Korn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58c95d12662f4e939efa01dd3b1e6942 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
por: Anna Kanerva, et al.
Publicado: (2008) -
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Gang Shi, et al.
Publicado: (2021) -
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
por: Huiya Huang, et al.
Publicado: (2019) -
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Sumanth Nagabushan, et al.
Publicado: (2021) -
A potential bat adenovirus-based oncolytic virus targeting canine cancers
por: Hiromichi Matsugo, et al.
Publicado: (2021)